002393.SZ
002393.SZ
CNE100000NJ9
LISHENGPHARMA
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
4.39B EUR
4.38B EUR
6.1B EUR
5.59B EUR
Enterprise Value
2.19B EUR
3.14B EUR
4.65B EUR
4.1B EUR
Valuation Multiples
Trailing P/E
29.08x
35.39x
15.83x
14.4x
Forward P/E
--
--
--
--
Price to Sales
3.37x
4.27x
5.65x
5.01x
Price to Book
1x
0.98x
1.32x
1.21x
EV/Revenue
1.68x
3.06x
4.31x
3.67x
EV/EBITDA
11.88x
23.02x
10.57x
9.21x
Price to FCF (P/FCF)
12.69x
89.99x
36.96x
34.91x
EV/FCF
6.32x
64.47x
28.19x
25.59x
FCF Yield
7.88%
1.11%
2.71%
2.86%
ende